Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer

Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer

Bibliographic Details
Main Authors:	Wang, X, Zuo, D, Chen, Y, Li, W, Liu, R, He, Y, Ren, L, Zhou, L, Deng, T, Ying, G, Ba, Y
Format:	Online
Language:	English
Published:	Nature Publishing Group 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229635/

Similar Items

Shed syndecan-2 inhibits angiogenesis
by: De Rossi, Giulia, et al.
Published: (2014)

Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation
by: Haywood-Watson, Ricky J., et al.
Published: (2011)

Antithrombin Regulates Matriptase Activity Involved in Plasmin Generation, Syndecan Shedding, and HGF Activation in Keratinocytes
by: Chen, Ya-Wen, et al.
Published: (2013)

Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors
by: Popova, Taissia G, et al.
Published: (2006)

Shed syndecan-2 enhances tumorigenic activities of colon cancer cells
by: Choi, Sojoong, et al.
Published: (2015)

Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3–Sensitive Metalloproteinase
by: Fitzgerald, Marilyn L., et al.
Published: (2000)

Suppressing Syndecan-1 Shedding Ameliorates Intestinal Epithelial Inflammation through Inhibiting NF-κB Pathway and TNF-α
by: Zhang, Yan, et al.
Published: (2016)

Syndecan-1 Expression Is Associated with Tumor Size and EGFR Expression in Colorectal Carcinoma: A Clinicopathological Study of 230 Cases
by: Kim, Su Young, et al.
Published: (2015)

Immunohistochemical Expression of Heparanase Isoforms and Syndecan-1 Proteins in Colorectal Adenomas
by: Waisberg, J., et al.
Published: (2016)

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
by: Pan YH, et al.
Published: (2018-08-01)

Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone
by: Carrasco, J, et al.
Published: (2015)

Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathway
by: Wu Y, et al.
Published: (2018-09-01)

Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer
by: Chen, L, et al.
Published: (2014)

Growth factor–induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells
by: Ding, Kan, et al.
Published: (2005)

Novel Processed Form of Syndecan-1 Shed from SCC-9 Cells Plays a Role in Cell Migration
by: Aragão, Annelize Z. B., et al.
Published: (2012)

Is EGFR expression altered following postoperative chemotherapy for colorectal adenocarcinoma?
by: Khalifa, Mahmoud A, et al.
Published: (2006)

Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis
by: Wei, Hao-tang, et al.
Published: (2015)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
by: Goutebroze, Laurence, et al.
Published: (2003)

Involvement of the Histone Acetyltransferase AtHAC1 in the Regulation of Flowering Time via Repression of FLOWERING LOCUS C in Arabidopsis1[W][OA]
by: Deng, Weiwei, et al.
Published: (2007)

Syndecan-Regulated Receptor Signaling
by: Rapraeger, Alan C.
Published: (2000)

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients
by: Yan, Han, et al.
Published: (2015)

Low Molecular Weight Heparin Relieves Experimental Colitis in Mice by Downregulating IL-1β and Inhibiting Syndecan-1 Shedding in the Intestinal Mucosa
by: Wang, Xian-fei, et al.
Published: (2013)

Coincidence of Expression of Syndecan 4 with VEGF in Pulp Tissue of Mesiodens
by: Mukhaled L Ali, et al.
Published: (2018-08-01)

Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis
by: Haddad, Oualid, et al.
Published: (2015)

Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
by: Jung, O, et al.
Published: (2016)

The involvement of Kras gene 3′-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis
by: Ying, Hou-Qun, et al.
Published: (2014)

Heparanase activates the syndecan-syntenin-ALIX exosome pathway
by: Roucourt, Bart, et al.
Published: (2015)

Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
by: Li, X, et al.
Published: (2012)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
by: Zheng, G, et al.
Published: (2014)

Syndecans in tumor cell adhesion and signaling
by: Beauvais, DeannaLee M, et al.
Published: (2004)

Active Role of the Predecidual-Like Zone in Endometrial Shedding in a Mouse Menstrual-Like Model
by: Xu, X., et al.
Published: (2013)

Syndecan-1 in the Mouse Parietal Peritoneum Microcirculation in Inflammation
by: Kowalewska, Paulina M., et al.
Published: (2014)

Sodium–hydrogen exchanger NHA1 and NHA2 control sperm motility and male fertility
by: Chen, Su-Ren, et al.
Published: (2016)

Syndecan expressions in the human amnion and chorionic plate
by: Lorenzi, T., et al.
Published: (2010)

Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
by: Qu, X, et al.
Published: (2016)

Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis
by: Liu Y, et al.
Published: (2018-09-01)

Specific inhibition of ectodomain shedding of glycoprotein lba by targeting its juxtamembrane shedding cleavage site
by: Liang, X, et al.
Published: (2013)

Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance
by: Zheng, D., et al.
Published: (2016)

BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway
by: Li, X, et al.
Published: (2013)

Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer
by: Shen, L, et al.
Published: (2014)